1. Introduction {#sec1}
===============

Acute pancreatitis (AP) is a potentially life-threatening acute inflammatory disease of the pancreas. It is characterized by a systemic inflammatory response, with a growing number of hospitalizations each year, and it is associated with a mortality ranging from 3 to 30% in the world \[[@B1], [@B2]\]. In addition to gallstones and alcohol \[[@B3], [@B4]\], hypertriglyceridemia (HTG) is considered the third most common etiology of AP and accounts for 1--12% of AP cases \[[@B5]--[@B7]\].

It is reported that hypertriglyceridemia affects approximately one-quarter of the United States (US) population \[[@B8]\]. It is reported that 12% to 38% of AP patients have a history of a lipid disturbance \[[@B9]\]. According to the Guidelines of the American College of Gastroenterology and the Endocrine Society, high TG levels (≥1000 mg/dL) should be considered as a risk factor for developing acute pancreatitis \[[@B10], [@B11]\]. Elevated serum triglycerides (TGs) have been positively associated with the risk of AP, but the exact mechanism remains nebulous. As diabetes represents metabolic disorders, the endocrine function of the pancreas is affected, altering the carbohydrate and lipid metabolism. Lai et al. \[[@B12]\] reported that Chinese patients with diabetes are at elevated risk of AP in a population-based cohort study. Another study proposed that the risk of AP in diabetic patients can be reduced with better blood sugar control \[[@B13]\]. Furthermore, another recent study reported that increased lipid peroxidation associated with chronic hyperglycemia may be a key event in the pathogenesis of AP \[[@B14]\]. The present study showed that not all patients with HTG would develop AP, and the risk factors associated with AP in severe HTG patients are not well clarified. More importantly, a few studies have evaluated the development of AP in patients with severe HTG. Given the abovementioned gaps and information, we conduct a retrospective case-control study to assess the risk factors of HTG-AP.

2. Patients and Methods {#sec2}
=======================

The First Affiliated Hospital of Nanjing Medical University is an integrated healthcare delivery system in Eastern China. Data available for this study included demographic data, diagnoses, medication dispensing, and laboratory results. The hospital has an electronic health medical record system and a paper-based medical records library, which allow access to more detailed information and was included in this study.

HNAP and HIAP patients with a fasting triglyceride level of \>1000 mg/dl were retrospectively analyzed in The First Affiliated Hospital of Nanjing Medical University from January 1, 2014, to December 31, 2016. Among these patients, those with biliary pancreatitis, alcoholic pancreatitis, idiopathic causes, traumatic pancreatitis, and other undefined recorded causes were excluded from our study. The diagnosis of HIAP was made if the patients had AP with the serum total triglyceride (TG) level of \>11.3 mmol/L (1000 mg/dl). The AP diagnosis was performed based on the following features: typical upper abdominal pain (persistent, severe, radiating pain), laboratory tests (amylase and lipase), and evidence of pancreatitis upon abdominal imaging \[[@B14]\]. CT scans were performed on all patients upon admission to the hospital to differentiate HIAP from other medical conditions. During the study period, a total of 155 patients were diagnosed with hypertriglyceridemia. According to our criteria, 124 patients with severe hypertriglyceridemia were included in this study; of which, 62 patients were in the HIAP group and 62 patients were in the HNAP group ([Figure 1](#fig1){ref-type="fig"}).

The information on demographic data, history of diabetes, blood pressure, history of alcohol and cigarettes, and biochemical data was carefully collected. Data regarding deaths, length of hospital stay, and intensive care unit (ICU) admission were recorded and analyzed.

All the patients whose data were collected for this study\'s purpose provided written informed consent for the acquisition, analysis, and publishing of the anonymized data collected during their hospital admission.

2.1. Statistical Analysis {#sec2.1}
-------------------------

*P* \< 0.05 was considered statistically significant, and all statistical analyses were performed by using SPSS17.0 software package. Continuous variables are expressed as mean ± SE, and comparisons between groups were performed by using the *t*-test. Categorical variables were compared between groups by using the Pearson *χ*^2^ test.

3. Results {#sec3}
==========

3.1. Baseline Characteristics of the Study Sample {#sec3.1}
-------------------------------------------------

The baseline characteristics of hypertriglyceridemia patients with or without AP are summarized in [Table 1](#tab1){ref-type="table"}; a total of 124 patients with severe hypertriglyceridemia were included in this study. Differences between groups were analyzed by the chi-squared test or Fisher exact tests. Age, gender, weight, blood pressure, and mortality and survival rate were well balanced between the groups. The HIAP group were more likely to have a significantly higher proportion of diabetes (*P*=0.001) and higher fasting glycemia (*P* \< 0.001) than the HNAP group. Although there is no statistical difference, a high percentage of smoking history and drinking history was also observed in the HIAP group.

3.2. Univariate Logistic Regression {#sec3.2}
-----------------------------------

To investigate the risk factors contributing HIAP occurrence, we examined the potential variables and analyzed them by univariate analysis, as shown in [Table 2](#tab2){ref-type="table"}. Univariate analysis identified that younger age (OR 0.901, 95% CI 0.931--4.22; *P* \< 0.001) and lower HDL-c (OR 0.995, 95% CI 0.992--0.998; *P*=0.003) were significantly associated with HIAP occurrence. In addition, the presence of pancreatitis was associated with higher hepatic biochemical indexes, such as GGT, LDH, AST, ALT, and alkaline phosphatase. Furthermore, a history of diabetes was more common in patients with HIAP (OR 4.321, 95% CI 1.683--11.096; *P*=0.002), and higher fasting glycemia (OR 1.126, 95% CI 1.040--1.218; *P*=0.003) was associated with the presence of pancreatitis.

3.3. Multivariate Logistic Regression {#sec3.3}
-------------------------------------

A binomial logistic regression was performed to ascertain the effects of independent variables on the likelihood that patients had acute pancreatitis with severe hypertriglyceridemia.

Introducing the variables with *P* value \<0.05 and higher clinical relevance in univariate analysis into multivariate analysis ([Table 3](#tab3){ref-type="table"}), the result indicated that diabetes (OR 6.41, 95% CI 1.4933--27.496; *P*=0.012) and lower age (OR 0.95, 95% CI 0.9--0.9992; *P*=0.047) were associated with an increased likelihood of developing HIAP.

3.4. ICU Admission and Length of Hospital Stay {#sec3.4}
----------------------------------------------

Comparison between HIAP patients with diabetes (*n* = 22) and those without (*n* = 40) was performed. ICU admission was more frequent in the HIAP patients with diabetes than those without, and obviously, the difference was statistically significant (*χ*^2^ = 5.573, *P*=0.018) ([Table 4](#tab4){ref-type="table"}). Similarly, median length of hospital stay in HIAP patients with diabetes was 15.2 days (9.0--18.3) vs. 9.5 days (5.3--16.0) in the nondiabetes group (*P*=0.06) ([Table 5](#tab5){ref-type="table"}).

4. Discussion {#sec4}
=============

In the present study, univariate and multivariate analyses identified that a history of diabetes and younger age were independent risk factors for acute pancreatitis in patients with severe hypertriglyceridemia. Moreover, we found that diabetes can influence the management of patients with HIAP, increase ICU admission rate, and prolong hospital length of stay. To our knowledge, this is the first case-control study to examine the risk factors in people with severe hypertriglyceridemia in China.

The mechanism by which HTG leads to acute pancreatitis has not been clarified so far; however, several pathogenetic theories have been proposed. Bhatia et al. \[[@B15], [@B16]\] proposed that HTG can impair circulatory blood flow in the pancreatic, leading to an increase in affinity between hemoglobin and oxygen, which may induce tissue hypoxia. Poonuru et al. \[[@B17]\] demonstrated that triglycerides in the pancreas are broken down by pancreatic lipases into free fatty acids and excessively produced free fatty acids accumulate in the pancreatic microcirculation, leading to obstruction and ischemia, which can induce acute pancreatitis. This result can also increase the acidity of the pancreas, which makes the pancreas prone to acute inflammation through activation of trypsinogen. In our study, we found that a history of smoking and drinking was more common in HIAP patients. A recent comprehensive study analyzing 2810 patients demonstrated that cigarette smoking and drinking were associated with non-gallstone-related pancreatitis, including hypertriglyceridemia-induced acute pancreatitis \[[@B18]\]. Another study noted that cigarette smoking might contribute to hyperlipidemic acute pancreatitis recurrence \[[@B19]\]. Future studies are needed to clarify possible changes in the metabolic and molecular characteristics of HIAP related to tobacco use and drinking.

HTG has also been shown to exacerbate other experimental models of acute pancreatitis \[[@B20]\]. Diabetes can lead to lipid metabolism disorder, which aggravates the process and induces pancreatitis, but further experiments are needed to support this standpoint. A recent study of 784 patients with acute pancreatitis also reported that 67% patients with diabetes or impaired glucose tolerance had a secondary risk factor for hypertriglyceridemia-induced acute pancreatitis \[[@B21]\]. The most interesting finding of our study is that diabetes and younger age were independently associated with developing HIAP. Furthermore, the prevalence of ICU admission and median hospital days were higher in HIAP patients with diabetes. These results are consistent with those of previous studies.

There are some special features of HTG-AP different from AP of other etiologies that are frequently discussed. Some older studies proposed that HTG may play a critical role in the development of respiratory failure and other severe complications associated with acute pancreatitis \[[@B22], [@B23]\]. A French cohort study showed that the severity of HTG-induced AP was higher than that of AP induced by gallstones or alcohol \[[@B24]\]. Furthermore, HTG-induced AP is found to have a more severe prognosis, longer hospitalization, and more frequent pancreatic necrosis in patients \[[@B25]\]. In addition, an important practical point from one study showed that some AP patients manifested "normal" serum amylase activity levels although they had a raised urine amylase activity. Thus, the normal serum amylase activity does not exclude the diagnosis of acute pancreatitis in the presence of severe hypertriglyceridemia \[[@B22], [@B26], [@B27]\].

To date, the exact pathophysiological mechanism of HTG-induced AP still remains unclear and is a topic of controversial discussion. However, further research efforts in this area will be needed to spread more light into the risk factor of hypertriglyceridemia-induced acute pancreatitis.

This study has several limitations. First, our study used a retrospective design, which did not make dynamic analysis of patients\' data. Second, there is no information regarding additional factors that may have contributed to pancreatic-related events such as GLP-1 receptor agonists and DPP-4 inhibitors \[[@B28], [@B29]\]. The duration of diabetes and HTG was not considered in this study. Third, biochemistry data such as hemoglobin A1C, C-peptide, and insulin levels were not collected and analyzed in all patients. These data are important because they affect the severity of acute pancreatitis. Finally, sample size was small in our study; hence, the conclusion needs to be confirmed further in a large-scale prospective clinical observation.

5. Conclusions {#sec5}
==============

In conclusion, we demonstrated that diabetes and younger are vital and independent risk factors for acute pancreatitis in patients with severe hypertriglyceridemia. Moreover, the status of diabetes can aggravate the development of HIAP. These findings suggest that severe hypertriglyceridemia in young diabetic patients require more intensive pharmacologic therapeutic strategies, and HIAP patients who have diabetes should have more aggressive management. Further major clinical studies and animal experiments are needed to establish the influence of diabetes towards severity and mortality in HIAP.
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###### 

Baseline characteristics of the patients.

                              HNAP (*n* = 62)   HIAP (*n* = 62)   *P* value
  --------------------------- ----------------- ----------------- -----------
  Age (years)                                                     0.25
   ≥45                        23 (37%)          17 (27%)           
   \<45                       39 (63%)          45 (73%)           
  Gender                                                          0.09
   Male                       46 (74%)          37 (60%)           
   Female                     16 (26%)          25 (40%)           
  History of drinking                                             0.09
   Yes                        11 (18%)          19 (31%)           
   No                         51 (82%)          43 (69%)           
  History of smoking                                              0.08
   Yes                        10 (16%)          18 (29%)           
   No                         52 (84%)          44 (71%)           
  Weight (kg)                                                     0.58
   ≥70                        35 (56%)          38 (61%)           
   \<70                       27 (44%)          24 (39%)           
  Hypertension                                                    0.83
   Yes                        16 (26%)          15 (24%)           
   No                         46 (74%)          47 (76%)           
  History of diabetes                                             0.001
   Yes                        7 (11%)           22 (35%)           
   No                         55 (89%)          40 (65%)           
  Fasting glycemia (mmol/l)                                       \<0.001
   ≥6.1                       24 (39%)          44 (71%)           
   \<6.1                      38 (61%)          18 (29%)           

HNAP, hypertriglyceridemia patients without acute pancreatitis; HIAP, hypertriglyceridemia-induced acute pancreatitis.

###### 

Univariate logistic regression analysis.

                             *N*   OR      *z*     *P* value   LOR     UOR
  -------------------------- ----- ------- ------- ----------- ------- --------
  Gender                     124   1.672   1.33    0.183       0.784   3.563
  Age                        124   0.931   −4.22   \<0.001     0.901   0.963
  History of drinking        124   2.049   1.66    0.097       0.879   4.775
  History of smoking         124   1.752   1.28    0.2         0.743   4.130
  Weight                     124   1.016   1.16    0.246       0.989   1.043
  Hypertension               124   1.090   0.21    0.836       0.483   2.458
  Length of hospital stays   124   1.051   1.67    0.095       0.991   1.115
  History of diabetes        124   4.321   3.04    0.002       1.683   11.096
  Fasting glycemia           124   1.126   2.94    0.003       1.040   1.218
  Lipoprotein a              111   1.002   1.03    0.302       0.998   1.007
  LDL-c                      112   1.001   0.5     0.619       0.998   1.004
  HDL-c                      112   0.995   −2.97   0.003       0.992   0.998
  Total cholesterolemia      117   0.999   −0.53   0.598       0.996   1.003
  Direct bilirubin           124   1.011   1.47    0.142       0.996   1.027
  Triglycerides              124   0.998   −0.43   0.668       0.988   1.008
  Alkaline phosphatase       124   1.044   5.76    \<0.001     1.029   1.060
  GGT                        123   1.113   4.44    \<0.001     1.062   1.167
  LDH                        124   1.011   5.59    \<0.001     1.007   1.015
  AST                        122   1.125   5.26    \<0.001     1.076   1.176
  ALT                        122   0.993   −2.04   0.041       0.987   1.000

LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; GGT, gamma-galactosyltransferase; LDH, lactate dehydrogenase; AST, aspartate transaminase; ALT, alanine transaminase; OR, odds ratio.

###### 

Multivariate logistic regression analysis.

                                 OR     *z*     *P* value   LOR      UOR
  ------------------------------ ------ ------- ----------- -------- --------
  Age                            0.95   −1.99   0.047       0.9      0.9992
  History of drinking            1.88   0.77    0.441       0.3763   9.407
  History of diabetes mellitus   6.41   2.5     0.012       1.4933   27.496
  Fasting glycemia               1.09   1.85    0.064       0.9952   1.1883
  HDL-c                          1.01   1.05    0.292       0.9977   1.0077

HDL-c, high-density lipoprotein cholesterol; OR, odds ratio.

###### 

ICU admission.

  Monocentric   HIAP   *χ* ^2^   *P* value   
  ------------- ------ --------- ----------- -------
  ICU           7      10        5.573       0.018
  Non-ICU       33     12                     

HIAP, hypertriglyceridemia-induced acute pancreatitis; ICU, intensive care unit.

###### 

Length of hospital stay.

             Sample        Length of hospital stay   *z*               *P* value   
  ---------- ------------- ------------------------- ----------------- ----------- -------
  HIAP       Nondiabetes   40                        9.5 (5.3, 16.0)   0.614       0.006
  Diabetes   22            15.2 (9.0, 18.3)                                        

HIAP, hypertriglyceridemia-induced acute pancreatitis.
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